Healthcare
Live Price
Offline$83.00
+0.00% today
1Y Change
+45.61%
Window
Jun 25, 2025 → Jun 18, 2026
Coverage: 253 bars · Jun 25, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Drägerwerk AG & Co. KGaA (DGWPF) is a Healthcare stock with a market cap of $1.68B and listed on OTC. The stock last traded around $83.00 and up 45.6% across the available one-year price window (Jun 25, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +3.3%, EPS growth of +12.6%, a dividend yield of 2.3%. What stands out right now is revenue +3.3%, EPS +12.6%, free cash flow +60.8% with operating margin 7.0% and ROIC 7.1%. The dividend is present but secondary, with a yield around 2.3%. Valuation is more restrained than many high-expectation growth names at P/E 11.0 and price/sales 0.5. Stock Foundry combines DGWPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.3% vs +7.6% peer median
Operating Margin
Below sector median
+7.0% vs +19.4% peer median
P/E
Below sector median
11.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 30, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +3.3% and EPS at +12.6%, with operating margin around 7.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.3%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +2.8% over the next 5 trading days and finished higher after 1 of those reports.
| Quarter | EPS Δ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 30, 2026 | — | +0.0% | +8.3% | +8.3% |
2026 Mar 24, 2026 | +0.0% | +0.0% | +0.0% | +0.0% |
2025 Jul 29, 2025 | — | +0.0% | +0.0% | +0.0% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DGWPF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DGWPF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for DGWPF and SPY.

Company Overview
Drägerwerk AG & Co. KGaA
Other OTC
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.